Advertisement
Screener

OTC:AURX | Cash, Period Increase (Decrease) | Nuo Therapeutics, Inc.

1.3 / 5 stars · 32/120 Roast Me

Nuo Therapeutics, Inc. Cash, Period Increase (Decrease)

Discontinued › Balance Sheet › Assets

us-gaap:CashPeriodIncreaseDecrease · last filed 2014-08-14

  • Nuo Therapeutics, Inc. cash, period increase (decrease) for the quarter ending 2014-06-30 was $17.32M.
  • Nuo Therapeutics, Inc. cash, period increase (decrease) for the quarter ending 2014-03-31 was $4.37M, a 5.07% decline year-over-year.
  • Nuo Therapeutics, Inc. cash, period increase (decrease) for the quarter ending 2013-12-31 was -$1.36M.
  • Nuo Therapeutics, Inc. cash, period increase (decrease) for the quarter ending 2013-09-30 was $1.27M.
  • Nuo Therapeutics, Inc. cash, period increase (decrease) for fiscal 2013 was $670.91K, a 81.45% increase from fiscal 2012.
  • Nuo Therapeutics, Inc. cash, period increase (decrease) for fiscal 2012 was $369.75K, a 76.99% decline from fiscal 2011.
  • Nuo Therapeutics, Inc. cash, period increase (decrease) for fiscal 2011 was $1.61M.
Period endCash, Period Increase (Decrease) 3 monthCash, Period Increase (Decrease) 6 monthCash, Period Increase (Decrease) 9 monthCash, Period Increase (Decrease) 12 month
2014-06-30$17.32M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14
$21.69M
10-Q · filed 2014-08-14
$20.33M
derived: sum of 3 quarters · filed 2014-08-14
$21.60M
derived: sum of 4 quarters · filed 2014-08-14
2014-03-31$4.37M
10-Q · filed 2014-05-15
$3.01M
derived: sum of 2 quarters · filed 2014-05-15
$4.28M
derived: sum of 3 quarters · filed 2014-05-15
$437.49K
derived: sum of 4 quarters · filed 2014-08-14
2013-12-31-$1.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31
-$87.75K
derived: sum of 2 quarters · filed 2014-03-31
-$3.93M
derived: sum of 3 quarters · filed 2014-08-14
$670.91K
10-K · filed 2014-03-31
2013-09-30$1.27M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12
-$2.57M
derived: sum of 2 quarters · filed 2014-08-14
$2.03M
10-Q · filed 2013-11-12
-$1.19M
derived: sum of 4 quarters · filed 2014-08-14
2013-06-30-$3.84M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14
$758.66K
10-Q · filed 2014-08-14
-$2.46M
derived: sum of 3 quarters · filed 2014-08-14
-$5.17M
derived: sum of 4 quarters · filed 2014-08-14
2013-03-31$4.60M
10-Q · filed 2014-05-15
$1.38M
derived: sum of 2 quarters · filed 2014-05-15
-$1.33M
derived: sum of 3 quarters · filed 2014-05-15
-$1.26M
derived: sum of 4 quarters · filed 2014-05-15
2012-12-31-$3.22M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31
-$5.93M
derived: sum of 2 quarters · filed 2014-03-31
-$5.87M
derived: sum of 3 quarters · filed 2014-03-31
$369.75K
10-K · filed 2014-03-31
2012-09-30-$2.71M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12
-$2.65M
derived: sum of 2 quarters · filed 2013-11-12
$3.59M
10-Q · filed 2013-11-12
$5.02M
derived: sum of 4 quarters · filed 2013-11-12
2012-06-30$63.62K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08
$6.30M
10-Q · filed 2013-08-08
$7.73M
derived: sum of 3 quarters · filed 2013-08-08
$8.24M
derived: sum of 4 quarters · filed 2013-08-08
2012-03-31$6.23M
10-Q · filed 2013-05-09
$7.67M
derived: sum of 2 quarters · filed 2013-05-09
$8.18M
derived: sum of 3 quarters · filed 2013-05-09
$7.43M
derived: sum of 4 quarters · filed 2013-05-09
2011-12-31$1.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
$1.94M
derived: sum of 2 quarters · filed 2013-03-18
$1.20M
derived: sum of 3 quarters · filed 2013-03-18
$1.61M
10-K · filed 2013-03-18
2011-09-30$513.75K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14
-$234.97K
derived: sum of 2 quarters · filed 2012-11-14
$176.61K
10-Q · filed 2012-11-14
2011-06-30-$748.72K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14
-$337.14K
10-Q · filed 2012-08-14
2011-03-31$411.58K
10-Q · filed 2012-05-15